一图读懂IPO项目——同源康_老虎社区_美港股上老虎

一图读懂IPO项目——同源康

同源康是一家专注于研发治疗癌症和自身免疫性疾病的小分子创新药公司，成立于2017年。公司的核心业务模式包括通过内部进行小分子药物和其他相关创新药物种类（如PROTAC）的发现、开发及商业化，以解决在癌症领域，特别是肺癌领域未满足的需求。 @Seven8 @小虎征文 @爱发红包的虎妞 @话题虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":337970261868816,"tweetId":"337970261868816","gmtCreate":1723513540171,"gmtModify":1723513542051,"author":{"id":3499810068552833,"idStr":"3499810068552833","authorId":3499810068552833,"authorIdStr":"3499810068552833","name":"ZResearch","avatar":"https://static.tigerbbs.com/468520e1d318e94c52b3d5ea2ecd2e33","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"f48104d3aff74204841356e6c91c4d07-1","templateUuid":"f48104d3aff74204841356e6c91c4d07","name":"周度最佳创作者","description":"每周获得最佳精华帖的创作者","bigImgUrl":"https://static.tigerbbs.com/271475ceaf67d40016c8cfa16c08c8b3","smallImgUrl":"https://static.tigerbbs.com/5a6336061b9ba82ba9177c7ec476f5f2","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.01","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":260,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/25eb385d3f5b046e8a3c072136322a4a","width":"2480","height":"3508"}],"coverImages":[{"img":"https://static.tigerbbs.com/25eb385d3f5b046e8a3c072136322a4a","width":"2480","height":"3508"}],"title":"一图读懂IPO项目——同源康","html":"<html><head></head><body> <a href=\"https://laohu8.com/S/02410\">$同源康医药 -B(02410)$</a> \n<img src=\"https://static.tigerbbs.com/25eb385d3f5b046e8a3c072136322a4a\" tg-width=\"2480\" tg-height=\"3508\">\n同源康是一家专注于研发治疗癌症和自身免疫性疾病的小分子创新药公司，成立于2017年。公司的核心业务模式包括通过内部进行小分子药物和其他相关创新药物种类（如PROTAC）的发现、开发及商业化，以解决在癌症领域，特别是肺癌领域未满足的需求。 <a href=\"https://laohu8.com/U/20703384576125\">@Seven8</a> <a href=\"https://laohu8.com/U/3527667573852808\">@小虎征文</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a> <a href=\"https://laohu8.com/U/3502767768442965\">@话题虎</a> </body></html>","htmlText":"<html><head></head><body> <a href=\"https://laohu8.com/S/02410\">$同源康医药 -B(02410)$</a> \n<img src=\"https://static.tigerbbs.com/25eb385d3f5b046e8a3c072136322a4a\" tg-width=\"2480\" tg-height=\"3508\">\n同源康是一家专注于研发治疗癌症和自身免疫性疾病的小分子创新药公司，成立于2017年。公司的核心业务模式包括通过内部进行小分子药物和其他相关创新药物种类（如PROTAC）的发现、开发及商业化，以解决在癌症领域，特别是肺癌领域未满足的需求。 <a href=\"https://laohu8.com/U/20703384576125\">@Seven8</a> <a href=\"https://laohu8.com/U/3527667573852808\">@小虎征文</a> <a href=\"https://laohu8.com/U/20722186463466\">@爱发红包的虎妞</a> <a href=\"https://laohu8.com/U/3502767768442965\">@话题虎</a> </body></html>","text":"$同源康医药 -B(02410)$ 同源康是一家专注于研发治疗癌症和自身免疫性疾病的小分子创新药公司，成立于2017年。公司的核心业务模式包括通过内部进行小分子药物和其他相关创新药物种类（如PROTAC）的发现、开发及商业化，以解决在癌症领域，特别是肺癌领域未满足的需求。 @Seven8 @小虎征文 @爱发红包的虎妞 @话题虎","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/337970261868816","repostId":0,"isVote":1,"tweetType":1,"viewCount":727,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02410"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":277,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}